[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345625-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345625-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diabetes-and-cancer-specific-survival-a-nationwide-population-based-cohort-study-across-multiple-cancer-sites","Diabetes and Cancer-Specific Survival - A Nationwide Population-Based Cohort Study Across Multiple Cancer Sites","","Cancer patients with coexisting diabetes generally experience poorer survival than patients without diabetes. This study examined the relationship between type 2 diabetes and cancer-specific survival across 13 of the most common cancer sites using a nationwide, population-based Finnish cohort from the CARING Project. Among 49,799 incident cases, diabetes’ effect on prognosis varied by cancer type, with lower survival in several sites and higher survival in liver and rectal cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diabetes-and-cancer-specific-survival-a-nationwide-population-based-cohort-study-across-multiple-cancer-sites/345625/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diabetes-and-cancer-specific-survival-a-nationwide-population-based-cohort-study-across-multiple-cancer-sites/345625.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main research question of the study?","Question",{"text":63,"@type":64},"The study assessed how type 2 diabetes relates to cancer-specific survival across 13 common cancer sites in a nationwide Finnish population-based cohort.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How large was the cohort and how were patients grouped?",{"text":68,"@type":64},"The cohort included 49,799 incident cancer cases, with 25,899 cases in patients with diabetes and 23,900 in patients without diabetes.",{"name":70,"@type":61,"acceptedAnswer":71},"Did the effect of diabetes on survival look the same across all cancer types?",{"text":72,"@type":64},"No. Diabetes impact varied by cancer type, showing substantially lower survival for stomach, endometrial, and lympho-hematological cancers, while liver and rectal cancer showed higher survival among patients with diabetes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345625,1790386449,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nDiabetes and Cancer-Specific Survival: A Nationwide  \nPopulation-Based Cohort Study Across Multiple Cancer Sites  \nPetrus Lohi1  | Jari Haukka1,2  | Leo Niskanen3,4  | Anssi Auvinen1   \n1Tampere University, Faculty of Social Sciences, Tampere, Finland | 2Department of Public Health, University of Helsinki, Helsinki,  \nFinland | 3Department of Endocrinology, Päijät-Häme Central Hospital, Lahti, Finland | 4University of Eastern Finland, Kuopio, Finland Correspondence: Petrus Lohi ([petrus.lohi@tuni.fi](petrus.lohi@tuni.fi))  \nReceived: 5 November 2025 | Revised: 5 June 2026 | Accepted: 12 June 2026  \nKeywords: cancer | cohort | diabetes mellitus | survival  \nABSTRACT  \nBackground: Cancer patients with concurrent diabetes generally show poorer survival compared with nondiabetic patients. Aims: We examined the relationship between Type 2 diabetes and cancer-specific survival in the 13 most common cancer sites within a large population-based cohort in Finland. We hypothesized that survival would be lower among patients with diabetes across cancer types.  \nMethods and Results: The cohort, derived from the Finnish CARING Project, included 49 799 incident cancer cases: 25 899 in patients with diabetes and 23 900 in nondiabetic patients. The mean age at diagnosis was 72.2years, and 40.9% were women. During a mean follow-up of 3.8 years (188 329 person-years), 13 602 cancer deaths occurred. The impact of diabetes on prognosis varied by cancer type. Survival was substantially lower for stomach, endometrial, and lympho-hematological cancers, and slightly lower for colon and breast cancer. Conversely, patients with diabetes had higher survival for liver and rectal cancer. No notable differences were observed for pancreatic, bladder, kidney, prostate, lung, or nonmelanoma skin cancer.  \nConclusion: Future studies should focus on the biological and metabolic factors influencing cancer survival in patients with diabetes and on how treatment strategies can be optimized to reduce excess cancer mortality in this patient group.  \n1 | Introduction  \nObesity and Type 2 diabetes are known drivers of cancer progression [1]. According to a Danish study, 35% of people will develop diabetes during their lifetime, 44% will be diagnosed with cancer, and 15% will develop both [2] . In the UK, cancer has already surpassed cardiovascular disease as the leading cause of death among people with diabetes [3] .  \nThe association between Type 2 diabetes and cancer has been widely researched, and ample evidence has shown a link between the two diseases [4–6] . Metabolic changes in diabetes are postulated to enhance tumor proliferation. This is likely  \nmediated mainly by hyperglycemia and hyperinsulinemia, but other hormones, growth factors, and free fatty acids may also play a role. Dysregulation of the insulin-like growth factor (IGF) system, as well as various signaling pathways activated by inflammatory cytokines, adipocytokines, and other adhesion molecules, have been suggested to mediate the link between diabetes and cancer [7] . Multiple signaling pathways are involved in cancer development and in the process of acquiring the hallmarks of cancer that include abnormal survival, proliferation, metabolism, and angiogenesis [8] . The PI3K/AKT/mTOR pathway plays a central role in cell cycle and survival, apoptosis, and glucose metabolism [9] . In malignant pathologies, the dysregulation and hyperactivation of the mTOR cascade frequently  \n\n| Abbreviations: IGF, insulin-like growth factor; OAD, oral antidiabetic; SII, Social Insurance Institution. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Cancer Reports published by Wiley Periodicals LLC. |\n\nCancer Reports, 2026; 9:e70615 1 of 8  \n[https://doi.org/10.1002/cnr2.70615](htt","cbCainQ637oK15yi","https://ap.wps.com/l/cbCainQ637oK15yi","pdf",889729,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What was the main research question of the study?\",\"answer\":\"The study assessed how type 2 diabetes relates to cancer-specific survival across 13 common cancer sites in a nationwide Finnish population-based cohort.\"},{\"question\":\"How large was the cohort and how were patients grouped?\",\"answer\":\"The cohort included 49,799 incident cancer cases, with 25,899 cases in patients with diabetes and 23,900 in patients without diabetes.\"},{\"question\":\"Did the effect of diabetes on survival look the same across all cancer types?\",\"answer\":\"No. Diabetes impact varied by cancer type, showing substantially lower survival for stomach, endometrial, and lympho-hematological cancers, while liver and rectal cancer showed higher survival among patients with diabetes.\"}]","Diabetes and Cancer-Specific Survival - A Nationwide Population-Based Cohort Study Across Multiple Cancer Sites | PDF",1790058363,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/557b1f76516146f67525ce4d8c4c6bb0.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f5e5d83c9af9bafc0f0c28cb8b71064.webp",982,1290,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1f6ba6168759abf0f0d044c4080aad8.webp",981,1289,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/243576de7c6db670d3b34e08dda6f528.webp",980,1287]